Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice https://t.co/w35LiIMdNb
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2020 – Jun 2025Where it's discussed
-
X / Twitter43 posts
-
News42 articles
-
Blogs8 articles
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The discussions demonstrate a high level of interest and consensus on remdesivir’s promising results, exemplified by mentions of its effectiveness in human lung cells and animal models. Words like 'supports' and 'further confirms' highlight the perceived importance and potential impact of this research, reflected in both detailed scientific references and enthusiastic tone.
The majority of discussions clearly acknowledge the positive findings regarding remdesivir's effectiveness against SARS-CoV-2, with some emphasizing its potential as a treatment option.
Participants display strong curiosity by highlighting specific details of the research, such as its efficiency in human lung cells and mice models, indicating high relevance and engagement with the subject.
Many discussions reference detailed scientific aspects, including the mechanisms of action and research collaborations, showing a level of deep engagement, although some posts are more brief or supportive.
The tone and content suggest that the community perceives this research as highly impactful, with phrases that imply significant potential for clinical application, and references to support from prominent institutions and researchers.
Abstract in brief
- Remdesivir (RDV) effectively inhibits SARS-CoV-2 replication in human lung cells and airway tissues, showing stronger activity in these human models compared to Vero E6 cells.
- Researchers created a chimeric virus in mice containing the SARS-CoV-2 RNA polymerase to test remdesivir's in vivo efficacy, where RDV reduced lung viral load and improved lung function.
- These findings support the potential of remdesivir as a promising treatment for COVID-19, warranting further clinical investigation.
Top posts
Most liked on X and Bluesky@AnwaltUlbrich "Perfektes" Umfeld: Mark Denison von der Vanderbilt University Zitat: Mark Denison led the team that developed the Remdesivir drug to treat COVID-19. July 21, 2020 Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase https://t.co/JZ3Hl347DD
@jhas5 @KindeandTrue @keverington @lissnup @tommy_cleary @gdemaneuf @CharlesRixey @CentristXtreme @capitolsheila @zhiyanle @Muller_Lab @FoolsMultiply @Daoyu15 @Byron_Wan @BillyBostickson @franciscodeasis @GMWatch @MonaRahalkar @quay_dr @TheSeeker268 @mattwridley @ianbirrell @SharriMarkson @Tantalite @joshrogin @AGHuff @samhusseini From this Jul 2020 publication https://t.co/5s3fHJ5VBq Authors include Ralph S Baric, PLUS Gilead Sciences makers of Veklury which was granted EUA on May 1, 2020 https://t.co/0uvUC5zzD8
"Remdesivir [https://t.co/t3Aa9UR4Oq] inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice" https://t.co/NoyeEaGBFE
@Jikkyleaks @Melchizedek1972 I could sound as a broken disc, but: https://t.co/E693P53UHL Look for one usual suspect here: https://t.co/XKalkkK7ki And one of his pupils end working at Merck: https://t.co/yMpOMvhYtJ https://t.co/auPZEytzRL https://t.co/2rUHhs8PxR
Los estudios pre-clínicos sugieren que sí sirve, pero en esos estudios se dio extremadamente temprano: 12 horas post-infección en macacos: https://t.co/QQeN92Q869 24 horas post-infección en modelo murino: https://t.co/F6Ee6YuGIf
All mentions
Comparing COVID-19 Vaccines and Treatments: Key Insights
This video discusses the differences between COVID-19 vaccines and treatments. It highlights the global effort to find effective therapies like the REGN-COV2 antibody cocktail, which shows promise in reducing virus…
REGN-COV2 Antibodies: Effective COVID-19 Treatment Insights
A global effort is underway to find effective treatments for COVID-19, focusing on the antibody cocktail REGN-COV2. This video explores how REGN-COV2 significantly reduces virus levels in animal models, providing…
RT @FrauHodl: @AnwaltUlbrich "Perfektes" Umfeld: Mark Denison von der Vanderbilt University Zitat: Mark Denison led the team that develope…
RT @FrauHodl: @AnwaltUlbrich "Perfektes" Umfeld: Mark Denison von der Vanderbilt University Zitat: Mark Denison led the team that develope…
RT @FrauHodl: @AnwaltUlbrich "Perfektes" Umfeld: Mark Denison von der Vanderbilt University Zitat: Mark Denison led the team that develope…
@AnwaltUlbrich "Perfektes" Umfeld: Mark Denison von der Vanderbilt University Zitat: Mark Denison led the team that developed the Remdesivir drug to treat COVID-19. July 21, 2020 Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase https://t.co/JZ3Hl347DD
@Jikkyleaks @Melchizedek1972 I could sound as a broken disc, but: https://t.co/E693P53UHL Look for one usual suspect here: https://t.co/XKalkkK7ki And one of his pupils end working at Merck: https://t.co/yMpOMvhYtJ https://t.co/auPZEytzRL https://t.co/2rUHhs8PxR
RT @biorxiv_pubd: Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymeras…
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. published as: https://t.co/sLrmXYaM8D @cellreports #biorxiv
RT @victoriacyanide: Similar to what has been observed with #remdesivir, authors show correlation between formation of intracellular 3'dATP…
Similar to what has been observed with #remdesivir, authors show correlation between formation of intracellular 3'dATP and cytotoxicity (LC50) in 4 cancer cell lines in vitro. 2/3 https://t.co/DOUmM45k0p https://t.co/3EL6pCyzz4 https://t.co/ZUAByckiVF
@jhas5 @KindeandTrue @keverington @lissnup @tommy_cleary @gdemaneuf @CharlesRixey @CentristXtreme @capitolsheila @zhiyanle @Muller_Lab @FoolsMultiply @Daoyu15 @Byron_Wan @BillyBostickson @franciscodeasis @GMWatch @MonaRahalkar @quay_dr @TheSeeker268 @mattwridley @ianbirrell @SharriMarkson @Tantalite @joshrogin @AGHuff @samhusseini From this Jul 2020 publication https://t.co/5s3fHJ5VBq Authors include Ralph S Baric, PLUS Gilead Sciences makers of Veklury which was granted EUA on May 1, 2020 https://t.co/0uvUC5zzD8
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/83Oo5crbif
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/Iqx8ijQagf
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase ... https://t.co/wmrkzAn1G4
Los estudios pre-clínicos sugieren que sí sirve, pero en esos estudios se dio extremadamente temprano: 12 horas post-infección en macacos: https://t.co/QQeN92Q869 24 horas post-infección en modelo murino: https://t.co/F6Ee6YuGIf
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice: Cell Reports https://t.co/06ShyMvR3D
https://t.co/Vtqw2W5OHS Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/SuuSqDtwN9
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
RT @CellReports: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice…
Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice https://t.co/w35LiIMdNb
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/91AIlQOJGQ
(comprovações importantes) Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/0e662tzW7Y
(Cited from “Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice”, by Andrea J. Pruijssers, et al, Cell Reports (2020), https://t.co/zqGw27o2VA)
Another co-authored paper by Mark Denison further supports the use of remdesivir for the treatment of COVID-19: https://t.co/MAMw0CMP4o @CellReports @CellPressNews @CellCellPress @VUMCResearch @VUMC_Vaccines @VanderbiltU
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice https://t.co/6zgznVSxMo #AyudaBiblioteca https://t.co/A6SBds3sBz
RT @mqzspa: "Remdesivir [https://t.co/t3Aa9UR4Oq] inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 R…
RT @mqzspa: "Remdesivir [https://t.co/t3Aa9UR4Oq] inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 R…
RT @mqzspa: "Remdesivir [https://t.co/t3Aa9UR4Oq] inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 R…
"Remdesivir [https://t.co/t3Aa9UR4Oq] inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice" https://t.co/NoyeEaGBFE
Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. - ScienceDirect https://t.co/rB9Hu5zVka